Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Illusory Responses across the Lewy Body Disease Spectrum.
Shahid M, Rawls A, Ramirez V, Ryman S, Santini VE, Yang L, Sha SJ, Hall JN, Montine TJ, Lin A, Tian L, Henderson VW, Cholerton B, Yutsis M, Poston KL. Shahid M, et al. Among authors: cholerton b. Ann Neurol. 2023 Apr;93(4):702-714. doi: 10.1002/ana.26574. Epub 2023 Feb 2. Ann Neurol. 2023. PMID: 36511519 Free PMC article.
Estrogen and Alzheimer's disease: the story so far.
Cholerton B, Gleason CE, Baker LD, Asthana S. Cholerton B, et al. Drugs Aging. 2002;19(6):405-27. doi: 10.2165/00002512-200219060-00002. Drugs Aging. 2002. PMID: 12149049 Review.
Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S. Reger MA, et al. Among authors: cholerton b. Neurobiol Aging. 2004 Mar;25(3):311-4. doi: 10.1016/S0197-4580(03)00087-3. Neurobiol Aging. 2004. PMID: 15123336 Clinical Trial.
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S. Watson GS, et al. Am J Geriatr Psychiatry. 2005 Nov;13(11):950-8. doi: 10.1176/appi.ajgp.13.11.950. Am J Geriatr Psychiatry. 2005. PMID: 16286438 Clinical Trial.
Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.
Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frölich L, Craft S. Watson GS, et al. Neurobiol Aging. 2006 Jan;27(1):38-41. doi: 10.1016/j.neurobiolaging.2004.11.011. Neurobiol Aging. 2006. PMID: 16298239 Clinical Trial.
Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S. Reger MA, et al. Among authors: cholerton b. Neurology. 2008 Feb 5;70(6):440-8. doi: 10.1212/01.WNL.0000265401.62434.36. Epub 2007 Oct 17. Neurology. 2008. PMID: 17942819 Clinical Trial.
87 results